Experiences of young mothers with the uptake of Sulfadoxine-Pyrimethamine for intermittent preventive treatment of malaria in pregnancy: a cross-sectional study in the Lake endemic region, Kenya

Experiences of young mothers with the uptake of Sulfadoxine-Pyrimethamine for intermittent preventive treatment of malaria in pregnancy: a cross-sectional study in the Lake endemic region, Kenya

BackgroundA substantial proportion of the world population is affected by malaria with 241 million malaria cases reported globally. Intermittent Preventive Treatment in pregnancy (IPTp) with Sulfadoxine-Pyrimethamine (SP) is an effective chemotherapy but its utilisation has not been optimised. Few s...

Full description

Bibliographic Details
Main Authors:	Dennis Juma Matanda, Tchaiwe Zulu, George Odwe, Oscar Okoth, Zoe Nakuya
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-03-01
Series:	Frontiers in Global Women's Health
Subjects:	malaria in pregnancy intermittent preventive treatment Sulfadoxine-Pyrimethamine young mothers Kenya
Online Access:	https://www.frontiersin.org/articles/10.3389/fgwh.2024.1294893/full

Similar Items

Women’s empowerment and uptake of sulfadoxine–pyrimethamine for intermittent preventive treatment of malaria during pregnancy: results from a cross-sectional baseline survey in the Lake endemic region, Kenya
by: George Odwe, et al.
Published: (2023-08-01)

Intermittent preventive treatment of malaria in pregnancy: a cross-sectional survey to assess uptake of the new sulfadoxine–pyrimethamine five dose policy in Ghana
by: Ivy Owusu-Boateng, et al.
Published: (2017-08-01)

Sulfadoxine/Pyrimethamine Intermittent Preventive Treatment for Malaria during Pregnancy
by: Philippe Deloron, et al.
Published: (2010-11-01)

Artesunate-, sulfadoxine-, and pyrimethamine-induced cardiotoxicity
by: Divya Goel, et al.
Published: (2016-01-01)

Superiority trial of intermittent treatment with dihydroartemisinin–piperaquine versus sulfadoxine–pyrimethamine for the prevention of malaria during pregnancy
by: Roland Nnaemeka Okoro, et al.
Published: (2023-01-01)

The Comparative Effects of Antenatal Azithromycin and Sulfadoxine-pyrimethamine on Maternal Malaria during Pregnancy
by: Ganiyu Olanipekun Ahmed, et al.
Published: (2024-10-01)

Predictors for the uptake of optimal doses of sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria during pregnancy in Tanzania: further analysis of the data of the 2015–2016 Tanzania demographic and health survey and malaria indicator survey
by: Vivian Mushi, et al.
Published: (2021-02-01)

Impact of intermittent preventive treatment of malaria in pregnancy with dihydroartemisinin-piperaquine versus sulfadoxine-pyrimethamine on the incidence of malaria in infancy: a randomized controlled trial
by: Abel Kakuru, et al.
Published: (2020-08-01)

Intermittent screening and treatment with artemether–lumefantrine versus intermittent preventive treatment with sulfadoxine–pyrimethamine for malaria in pregnancy: a facility-based, open-label, non-inferiority trial in Nigeria
by: Ekpereonne Esu, et al.
Published: (2018-07-01)

Determinants of uptake of intermittent preventive treatment for malaria with sulfadoxine pyrimethamine in pregnancy: a cross-sectional analytical study in the Sekondi-Takoradi Metropolis of Ghana
by: Francis Anto, et al.
Published: (2021-10-01)

Effectiveness of intermittent preventive treatment in pregnancy with sulfadoxine-pyrimethamine: An in silico pharmacological model
by: Mila Nu Nu Htay, et al.
Published: (2020-01-01)

A roadmap for understanding sulfadoxine-pyrimethamine in malaria chemoprevention
by: Thiery Masserey, et al.

Comparison of the efficacy of artemether-lumefantrine vs. artesunate plus sulfadoxine-pyrimethamine in children with uncomplicated falciparum malaria
by: Rachmawati Rachmawati, et al.
Published: (2010-04-01)

Determinants of uptake of intermittent preventive treatment during pregnancy: a review
by: Elaine Roman, et al.
Published: (2019-11-01)

Intermittent preventive treatment with sulfadoxine-pyrimethamine does not modify plasma cytokines and chemokines or intracellular cytokine responses to <it>Plasmodium falciparum </it>in Mozambican Children
by: Quelhas Diana, et al.
Published: (2012-01-01)

Molecular determinants of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum in Nigeria and the regional emergence of dhps 431V
by: Mary C. Oguike, et al.
Published: (2016-12-01)

Facteurs prédictifs de l'échec du Traitement Préventif Intermittent du paludisme à la sulfadoxine à pyriméthamine (TPIp-SP) dans une population de femmes enceintes à Yaoundé
by: Félix Essiben, et al.
Published: (2016-03-01)

Safety and efficacy of intermittent presumptive treatment with sulfadoxine-pyrimethamine using rapid diagnostic test screening and treatment with dihydroartemisinin-piperaquine at the first antenatal care visit (IPTp-SP+): study protocol for a randomized controlled trial
by: Jean-Bertin Bukasa Kabuya, et al.
Published: (2021-11-01)

Efficacy of Pyrimethamine/Sulfadoxine Versus Chloroquine for the Treatment of Uncomplicated Falciparum Malaria in Children Aged Under 5 Years
by: H Chen, et al.
Published: (2013-03-01)

Efficacy of Pyrimethamine/Sulfadoxine versus Chloroquine for the Treatment of Uncomplicated Falciparum Malaria in Children Aged Under 5 Years
by: W Zheng, et al.
Published: (2013-03-01)

Evidence on sulfadoxine-pyrimethamine resistance molecular markers from India: interpret with caution
by: Nimita Deora, et al.
Published: (2024-07-01)

Markers of sulfadoxine–pyrimethamine resistance in Eastern Democratic Republic of Congo; implications for malaria chemoprevention
by: Marit van Lenthe, et al.
Published: (2019-12-01)

High prevalence of genotypes associated with sulfadoxine/pyrimethamine resistance in the rural area of Fougamou, Gabon
by: Fleuramie Mirembou Boukoumba, et al.
Published: (2021-06-01)

Chloroquine and Sulfadoxine–Pyrimethamine Resistance in Sub-Saharan Africa—A Review
by: Alexandra T. Roux, et al.
Published: (2021-06-01)

Traitement préventif intermittent à la sulfadoxine à pyriméthamine du paludisme chez les femmes enceintes: efficacité et observance dans deux hôpitaux urbains du Burkina Faso
by: Sanata Bamba, et al.
Published: (2013-03-01)

Comparative efficacy of chloroquine and pyrimethamine-sulfadoxine versus artemether and pyrimethamine-sulfadoxine in the treatment of uncomplicated falciparum malaria in children
by: Femmy Tambajong, et al.
Published: (2016-10-01)

Profile of molecular markers of Sulfadoxine-Pyrimethamine-resistant Plasmodium falciparum in individuals living in southern area of Brazzaville, Republic of Congo
by: Jean Claude Djontu, et al.
Published: (2024-12-01)

Surveillance for sulfadoxine-pyrimethamine resistant malaria parasites in the Lake and Southern Zones, Tanzania, using pooling and next-generation sequencing
by: Jeremiah M. Ngondi, et al.
Published: (2017-06-01)

Uptake of intermittent preventive treatment for malaria in pregnancy among women in selected communities of Ebonyi State, Nigeria
by: Christian Obasi Akpa, et al.
Published: (2019-12-01)

Frequency of Pfcrt T76 and Pfdhfr Asn-108 Drug Resistance Mutations in falciparum Malaria in Southeastern Malaria Endemic Area of Iran
by: MR Razavi, et al.
Published: (2008-03-01)

Frequency of Pfcrt T76 and Pfdhfr Asn-108 Drug Resistance Mutations in falciparum Malaria in Southeastern Malaria Endemic Area of Iran
by: MR Razavi, et al.
Published: (2008-05-01)

Nationwide Monitoring for Plasmodium falciparum Drug-Resistance Alleles to Chloroquine, Sulfadoxine, and Pyrimethamine, Haiti, 2016–2017
by: Eric Rogier, et al.
Published: (2020-05-01)

Increase in the prevalence of mutations associated with sulfadoxine–pyrimethamine resistance in Plasmodium falciparum isolates collected from early to late pregnancy in Nanoro, Burkina Faso
by: Esmée Ruizendaal, et al.
Published: (2017-04-01)

Efficacy of sulfadoxine-pyrimethamine and mefloquine for the treatment of uncomplicated Plasmodium falciparum malaria in the Amazon basin of Peru
by: Alan J. Magill, et al.
Published: (2004-06-01)

A cluster randomized trial of delivery of intermittent preventive treatment of malaria in pregnancy at the community level in Burkina Faso
by: Julie R. Gutman, et al.
Published: (2020-08-01)

Molecular identification of sulfadoxine-pyrimethamine resistance in malaria infected women who received intermittent preventive treatment in the Democratic Republic of Congo
by: Emrah Ruh, et al.
Published: (2018-01-01)

Gametocytaemia in senegalese children with uncomplicated Falciparum malaria treated with chloroquine, amodiaquine or sulfadoxine + pyrimethamine
by: Sokhina C.S, et al.
Published: (2001-09-01)

Occurrence of septuple and elevated Pfdhfr-Pfdhps quintuple mutations in a general population threatens the use of sulfadoxine-pyrimethamine for malaria prevention during pregnancy in eastern-coast of Tanzania
by: George M. Bwire, et al.
Published: (2020-07-01)

Stable high frequencies of sulfadoxine–pyrimethamine resistance associated mutations and absence of K13 mutations in Plasmodium falciparum 3 and 4 years after the introduction of artesunate plus sulfadoxine–pyrimethamine in Ujjain, Madhya Pradesh, India
by: Ashish Pathak, et al.
Published: (2020-08-01)

Therapeutic efficacy of sulfadoxine-pyrimethamine, amodiaquine and the sulfadoxine-pyrimethamine-amodiaquine combination against uncomplicated Plasmodium falciparum malaria in young children in Cameroon
by: Basco Leonardo K., et al.
Published: (2002-01-01)